Alveolar soft part sarcoma. A clinicopathologic and immunohistochemical study
β Scribed by Herbert E. Auerbach; John J. Brooks
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 969 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
The histogenesis of alveolar soft part sarcoma (ASPS) has been investigated since its description. Twenty ASPS cases were analyzed for immunohistochemical content, with emphasis directed toward the paraganglial, Schwann cell, and muscle theories of histogenesis. In addition, the cases were examined for possible prognostic clinical features. The clinical characteristics of the patients were similar to those reported previously concerning (1) average age (23 years); (2) ma1e:female ratio (1:l); and (3) predominant primary site (lower extremity, nine cases). Despite a local recurrence rate of 20% and a metastatic rate of 68% (including four at presentation), the natural history was often indolent and relapse commonly occurred very late. The average follow-up period was 10.1 years. While the overall 5-year survival was 671, only seven of 18 patients were alive without disease at last follow-up (1.7-32 years), and one patient died of tumor after a 28-year disease-free interval. Neither tumor size nor site appeared to affect prognosis. The tumors were analyzed immunohistochemically for neurofilament, S-100 protein, met-enkephalin, leu-enkephalin, acetylcholinesterase, crl-antichymotrypsin, Factor VIII-related antigen, serotonin, lysozyme, neuron-specific enolase, myoglobin, cytokeratins, desmin, and vimentin. Except for weak vimentin immunoreactivity, no other antigenic expression was detected despite multiple repeated experiments with several antibodies. S l O O protein which is present in virtually all granular cell tumors was absent in the cases of ASPS. The lack of detectable expression of neurofilament, met-enkaphalin and leu-enkaphalin, and neuron-specific enolase is interpreted as evidence against the paraganglial theory of histogenesis. Similarly, the repeated absence of the muscle proteins, desmin and myoglobin, in contrast to a previous report, is interpreted as evidence against a myogenic origin.
Cancer 60:66-73, 1987.
LVEOLAR SOFT PART SARCOMA (ASPS) was de-
A fined initially in 1952 by Christopherson et al.'
They presented 12 cases of a rare soft tissue tumor that showed remarkable uniformity and an alveolar pattern.
In their discussion, the authors considered the possibilities that ASPS represented metastatic renal cell carci-noma, endothelioma, liposarcoma, rhabdomyosarcoma, paraganglioma, or malignant granular-cell "myoblastoma." They concluded that the histogenesis was uncertain and favored the creation of the descriptive term, ASPS. The amount of attention and investigation which has followed is remarkable because malignant
π SIMILAR VOLUMES
This paper presents the case history of a 22-year-old woman with an alveolar soft part sarcoma of the scapular region. Treatment consisted of resection. Cytostatic medication with adriamycin and dacarbazine (DTIC) failed t o prevent rapid general metastatic growth.
## Abstract A clinical experience with radiotherapy in 18 patients with alveolar softβpart sarcoma is presented. Adjuvant radiotherapy was associated with prolonged local control in six of six patients without metastatic disease at diagnosis; later one patient relapsed systematically. Meaningful pa
Metastasis to the breast is uncommon, with an incidence of 0.5-3%. Alveolar soft part sarcoma is rare, accounting for < 1 % of malignant soft tissue tumors, which are themselves unusual. Excluding contralateral breast and hematologic malignant disease, the primary lesion in most cases of metastasis
Alveolar soft-part sarcoma (ASPS) is an unusual tumor of soft tissues; it has invariably ended in death from disseminated disease, and the lung has been the most common site of metastasis. We present a patient with ASPS with bilateral pulmonary tnetastases who achieved a complete response after bila